14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Insurance Company Fired Employee Over Her Discrimination Complaint, Federal Agency Charges - LITTL...
Read More >
On August 9, Oregon’s governor signed into law House Bill 2005, which establishes one of the most c...
Read More >
Company Fired Seventh-Day Adventist Because She Refused to Work on Her Sabbath, Federal Agency Charg...
Read More >
Whistleblower Developments is a periodic report covering significant cases, decisions, proposals, an...
Read More >
The National Labor Relations Board (NLRB) has held that a unit selected for organizing by the Intern...
Read More >
In Thomas v. Hyundai of Bedford, No. 108212 (January 23, 2020), the Eighth District Ohio Court of Ap...
Read More >